NutriBand (NTRB) Return on Capital Employed (2017 - 2026)
NutriBand's (NTRB) quarterly Return on Capital Employed came in at 115.54% in Q1 2026, down 156.0% year-on-year from 206.32% in Q1 2025, and up 23.38% quarter-over-quarter from 150.8% in Q4 2025.
NutriBand (NTRB) Return on Capital Employed (2017 - 2026) Analysis & Trends
NutriBand has disclosed Return on Capital Employed across 10 years of filings, most recently posting 115.54% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 115.54%, down 156.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 115.54% (down 156.0% YoY), and the FY2026 annual result was 123.69%, up 3427.0% from the prior year.
- Return on Capital Employed came in at 115.54% for Q1 2026 at NutriBand, up from 150.8% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 45.92% in Q1 2022 to a low of 166.65% in Q2 2025.
- The 5-year median for Return on Capital Employed is 61.9% (2023), against an average of 81.4%.
- Across the five-year window, Return on Capital Employed jumped 1095 bps in 2024 and slumped 11017 bps in 2025, its largest moves.
- NutriBand's Return on Capital Employed stood at 64.14% in 2022, then gained by 3 bps to 61.9% in 2023, then grew by 18 bps to 50.95% in 2024, then sank by 196 bps to 150.8% in 2025, then rose by 23 bps to 115.54% in 2026.
- The last three Return on Capital Employed figures came in at 115.54% (Q1 2026), 150.8% (Q4 2025), and 157.79% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -107.40% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -50.43% |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | -115.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -115.54% |
| Oct 31, 2025 | -150.80% |
| Jul 31, 2025 | -157.79% |
| Apr 30, 2025 | -166.65% |
| Jan 31, 2025 | -113.98% |
| Oct 31, 2024 | -50.95% |
| Jul 31, 2024 | -47.62% |
| Apr 30, 2024 | -57.90% |
| Jan 31, 2024 | -69.39% |
| Oct 31, 2023 | -61.90% |
| Jul 31, 2023 | -54.73% |
| Apr 30, 2023 | -58.05% |
| Jan 31, 2023 | -48.05% |
| Oct 31, 2022 | -64.14% |
| Jul 31, 2022 | -64.64% |
| Apr 30, 2022 | -55.69% |
| Jan 31, 2022 | -45.92% |
| Oct 31, 2021 | -38.30% |
| Jul 31, 2021 | -39.18% |
| Apr 30, 2021 | -35.78% |